Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery

NCT06205719 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2024-05-20

No results posted yet for this study

Summary

to investigate the effect of remazolam benzenesulfonate in patients with ocular fundus surgery, so as to guide clinical anesthesiologists to choose more appropriate anesthetic drugs in fundus surgery

Conditions

  • Remazolam Anesthesia
  • Postoperative Recovery

Interventions

DRUG

ciprofol

sedation

DRUG

Remazolam

sedation

DRUG

Flumazenil

antagonism

DRUG

Remifentanil

2ug/kg Remifentanil

Sponsors & Collaborators

  • Sichuan Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Ting Xu · Sichuan provincial Peopel'Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-05-30
Completion
2026-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06205719 on ClinicalTrials.gov